Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Zelman & Assoc Initiates Coverage On MasterBrand with Buy Rating

Zelman & Assoc Initiates Coverage On MasterBrand with Buy Rating

Zelman & Assoc initiates coverage on MasterBrand (NYSE:MBC) with a Buy rating.

byBenzinga Newsdesk

December 16, 2022

1 minute read

Zelman & Assoc initiates coverage on MasterBrand (NYSE:MBC) with a Buy rating.

Biden Vows To Hold Those Responsible For Silicon Valley Bank ‘Mess’ Fully Accountable

By Navdeep Yadav

March 12, 10:46 PM

President Joe Biden on SundaySBNY) failures “fully accountable.” What Happened: Biden, in a statement, said that U.S. Treasury…

SBNY

Analyst Ratings

Analyst Ratings for Silicon Laboratories

By Benzinga Insights

July 11, 1:05 PM

Analysts have provided the following ratings for Silicon Laboratories (NASDAQ:SLAB) within the last quarter:

SLAB

One-Two Punch for T-Mobile: Secures DoD Contract & Uber Deal

By Lekha Gupta

June 13, 1:23 PM

T-Mobile selected by U.S. Navy for $2.67 billion contract for wireless solutions. Partnership with Uber allows expansion of interactive screens in rideshare vehicles.

PKW

SVB Leerink Maintains Outperform on Viridian Therapeutics, Raises Price Target to $45

By Benzinga Newsdesk

January 9, 6:36 AM

SVB Leerink analyst Thomas Smith maintains Viridian Therapeutics (NASDAQ:VRDN) with a Outperform and raises the price target from $40 to $45.

VRDN

Zelman & Assoc Initiates Coverage On MasterBrand with Buy Rating

Related Posts

Biden Vows To Hold Those Responsible For Silicon Valley Bank ‘Mess’ Fully Accountable

Analyst Ratings for Silicon Laboratories

One-Two Punch for T-Mobile: Secures DoD Contract & Uber Deal

SVB Leerink Maintains Outperform on Viridian Therapeutics, Raises Price Target to $45